NBIX vs PAMT · P/E 45, rev $1.77B vs rev $306.5M
Neurocrine Biosciences Inc (NBIX) versus PAMT CORP (PAMT) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
PAMT CORP (PAMT) is a trucking company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported PAMT revenue for 2026-06-30 was $306.5M. Net income was -$7.5M. PAMT currently screens at market cap $302.9M.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. PAMT currently screens at market cap $302.9M.
Not investment advice. Open the NBIX and PAMT stock pages for the full models.
Not investment advice.